Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Robert Lustig, MD

Robert Lustig, MD Physician

Director, Network Development Program Professor of Clinical Radiation Oncology

Dr. Lustig is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Clinical Expertise:

  • Acoustic Neuroma (Vestibular Schwannoma)
  • Brain Cancer
  • Brain Metastases
  • Brain Tumors
  • Orbital Tumors
  • Proton Therapy
  • Radiation Oncology - Brain
  • Radiation Treatment
  • Skin Cancer
  • Spinal Cord Cancer
  • Spinal Tumor
  • Thyroid Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Jefferson Medical College
Residency: Metropolitan Hospital
Residency: Thomas Jefferson University Hospital

Memberships

American Association for Cancer Research (AACR), National American Association for the Advancement of Science (AAAS), National American College of Radiology (ACR), National American Society of Clinical Oncology (ASCO), National American Society of Therapeutic Radiology and Oncology (ASTRO), National Pediatric Proton Foundation, National Radiation Therapy Oncology Group (RTOG), National Society of Neuro-Oncology, National

Hospital Affiliation

Dr. Lustig is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Hill-Kayser Christine E, Tochner Zelig, Li Yimei, Kurtz Goldie, Lustig Robert A, James Paul, Balamuth Naomi, Womer Richard, Mattei Peter, Grupp Stephen, Mosse Yael P, Maris John M, Bagatell Rochelle: Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma. International journal of radiation oncology, biology, physics 104 (2): 401-408,2019.

Vogel Jennifer, Carmona Ruben, Ainsley Christopher G, Lustig Robert A: The Promise of Proton Therapy for Central Nervous System Malignancies. Neurosurgery 84 (5): 1000-1010,2019.

LaRiviere Michael J, Avery Robert A, Dolan J Gregory, Adamson Peter C, Zarnow Deborah M, Xie Yunhe, Avery Stephen M, Kurtz Goldie A, Hill-Kayser Christine E, Lustig Robert A, Lukens J Nicholas: Emergent radiation for leukemic optic nerve infiltration in a child receiving intrathecal methotrexate. Practical radiation oncology : 2019.

Bagley Stephen J, Schwab Robert D, Nelson Ernest, Viaene Angela N, Binder Zev A, Lustig Robert A, O'Rourke Donald M, Brem Steven, Desai Arati S, Nasrallah MacLean P: Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma. Journal of neuro-oncology 141 (2): 421-429,2019.

Galvez J, Eisenhower M, England W, Wartman E, Simpao A, Rehman M, Lustig R, Hribar M: An Interactive Virtual Reality Tour for Adolescents Receiving Proton Radiation Therapy: Proof-of-Concept Study. JMIR 2 (1): 2019.

Liu Tianrun, Xu Haineng, Huang Menggui, Ma Wenjuan, Saxena Deeksha, Lustig Robert A, Alonso-Basanta Michelle, Zhang Zhenfeng, O'Rourke Donald M, Zhang Lin, Gong Yanqing, Kao Gary D, Dorsey Jay F, Fan Yi: Circulating Glioma Cells Exhibit Stem Cell-like Properties. Cancer research 78 (23): 6632-6642,2018.

Birkhoff Susan D, Cantrell Mary Ann, Moriarty Helene, Lustig Robert: The Usability and Acceptability of a Patient-Centered Mobile Health Tracking App Among a Sample of Adult Radiation Oncology Patients. ANS. Advances in nursing science 41 (3): 243-259,2018.

Rathore Saima, Akbari Hamed, Doshi Jimit, Shukla Gaurav, Rozycki Martin, Bilello Michel, Lustig Robert, Davatzikos Christos: Radiomic signature of infiltration in peritumoral edema predicts subsequent recurrence in glioblastoma: implications for personalized radiotherapy planning. Journal of medical imaging (Bellingham, Wash.) 5 (2): 021219,2018.

Rathore S, Akbari H, Rozycki M, Abdullah KG, Nasrallah MP, Binder ZA., Davuluri RV, Lustig RA, Dahmane N, Bilello M, O’Rourke D & Davatzikos D: Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1 Scientific Reports 8 (1): 5087,2018.

Rathore Saima, Akbari Hamed, Rozycki Martin, Abdullah Kalil G, Nasrallah MacLean P, Binder Zev A, Davuluri Ramana V, Lustig Robert A, Dahmane Nadia, Bilello Michel, O'Rourke Donald M, Davatzikos Christos: Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Scientific reports 8 (1): 5087,2018.

Academic Contact Info

Perelman Center for Advanced Medicine
Department of Radiation Oncology
3400 Civic Center Blvd
2nd floor West

Philadelphia, PA 19104
Phone: (215) 349-8429
Patient appointments: 800-789-7366 (PENN)

Related Links